203 related articles for article (PubMed ID: 30672317)
21. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
[TBL] [Abstract][Full Text] [Related]
22. The Study of Mental and Resistance Training (SMART) study—resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial.
Fiatarone Singh MA; Gates N; Saigal N; Wilson GC; Meiklejohn J; Brodaty H; Wen W; Singh N; Baune BT; Suo C; Baker MK; Foroughi N; Wang Y; Sachdev PS; Valenzuela M
J Am Med Dir Assoc; 2014 Dec; 15(12):873-80. PubMed ID: 25444575
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
[TBL] [Abstract][Full Text] [Related]
24. Citicoline improves verbal memory in aging.
Spiers PA; Myers D; Hochanadel GS; Lieberman HR; Wurtman RJ
Arch Neurol; 1996 May; 53(5):441-8. PubMed ID: 8624220
[TBL] [Abstract][Full Text] [Related]
25. What is the clinically relevant change on the ADAS-Cog?
Schrag A; Schott JM;
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):171-3. PubMed ID: 22019547
[TBL] [Abstract][Full Text] [Related]
26. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
Jia J; Wei C; Liang J; Zhou A; Zuo X; Song H; Wu L; Chen X; Chen S; Zhang J; Wu J; Wang K; Chu L; Peng D; Lv P; Guo H; Niu X; Chen Y; Dong W; Han X; Fang B; Peng M; Li D; Jia Q; Huang L
Alzheimers Dement; 2016 Feb; 12(2):89-99. PubMed ID: 26086183
[TBL] [Abstract][Full Text] [Related]
27. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial.
Lam LC; Chan WC; Leung T; Fung AW; Leung EM
PLoS One; 2015; 10(3):e0118173. PubMed ID: 25826620
[TBL] [Abstract][Full Text] [Related]
28. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
[TBL] [Abstract][Full Text] [Related]
29. Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.
Liu-Ambrose T; Best JR; Davis JC; Eng JJ; Lee PE; Jacova C; Boyd LA; Brasher PM; Munkacsy M; Cheung W; Hsiung GR
Neurology; 2016 Nov; 87(20):2082-2090. PubMed ID: 27760869
[TBL] [Abstract][Full Text] [Related]
30. A naturalistic study of galantamine for Alzheimer's disease.
Brodaty H; Woodward M; Boundy K; Barnes N; Allen G;
CNS Drugs; 2006; 20(11):935-43. PubMed ID: 17044730
[TBL] [Abstract][Full Text] [Related]
31. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
32. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
33. Group- and Home-Based Cognitive Intervention for Patients with Mild Cognitive Impairment: A Randomized Controlled Trial.
Jeong JH; Na HR; Choi SH; Kim J; Na DL; Seo SW; Chin J; Park SA; Kim EJ; Han HJ; Han SH; Yoon SJ; Lee JH; Park KW; Moon SY; Park MH; Choi MS; Han IW; Lee JH; Lee JS; Shim YS; Kim JY
Psychother Psychosom; 2016; 85(4):198-207. PubMed ID: 27230861
[TBL] [Abstract][Full Text] [Related]
34. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
Alvarez-Sabín J; Román GC
Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
[TBL] [Abstract][Full Text] [Related]
35. An Updated Meta-Analysis of the Efficacy and Safety of Acupuncture Treatment for Vascular Cognitive Impairment Without Dementia.
Min D; Xu-Feng W
Curr Neurovasc Res; 2016; 13(3):230-8. PubMed ID: 27237931
[TBL] [Abstract][Full Text] [Related]
36. [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].
Gavrilova SI; Fedorova IaB; Gantman ; Kalyn IaB; Kolykhalov IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):16-20. PubMed ID: 22433803
[TBL] [Abstract][Full Text] [Related]
37. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
38. Galantamine for vascular cognitive impairment.
Birks J; Craig D
Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
[TBL] [Abstract][Full Text] [Related]
39. Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia.
Wang H; Zhang X; Wang P; Dai G; Liu L; Xu Y; Wang H; Zhang Y
Acta Neurol Belg; 2024 Jun; 124(3):871-877. PubMed ID: 38285160
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
